Literature DB >> 7884672

Solvent- and concentration-dependent molecular interactions of taxol (Paclitaxel).

S V Balasubramanian1, J L Alderfer, R M Straubinger.   

Abstract

Taxol (paclitaxel) is a promising anticancer agent that has been approved for the treatment of ovarian cancer and is under investigation for the therapy of other tumors. Paclitaxel is poorly soluble in water, and information on its physical behavior in hydrophilic and hydrophobic environments is limited. Circular dichroism (CD) and nuclear magnetic resonance spectroscopy were used to investigate the effect of solvent and drug concentration on the solution conformation of paclitaxel. CD is sensitive to paclitaxel's environment, owing to the presence of effective chromophores in the vicinity of several chiral centers. It was found that (i) the conformation of the paclitaxel side chain depends on the polarity of the solvent and (ii) paclitaxel has a tendency to undergo concentration-dependent aggregation in solvents such as chloroform. To account for the observations, a model is proposed in which paclitaxel molecules are held together in stacks by intermolecular hydrogen bonds involving all four exchangeable protons. Intermolecular interactions and self-association of paclitaxel may have impact not only on the physical stability of the drug in existing formulations or investigational vehicles but also on the effect of paclitaxel in the stabilization of cellular microtubules.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7884672     DOI: 10.1002/jps.2600831021

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Synthesis and Self-Assembly of a Mikto-Arm Star Dual Drug Amphiphile Containing both Paclitaxel and Camptothecin.

Authors:  A G Cheetham; P Zhang; Y-A Lin; R Lin; H Cui
Journal:  J Mater Chem B       Date:  2014-11-14       Impact factor: 6.331

2.  Dendrimer, liposomes, carbon nanotubes and PLGA nanoparticles: one platform assessment of drug delivery potential.

Authors:  Nishi Mody; Rakesh Kumar Tekade; Neelesh Kumar Mehra; Prashant Chopdey; Narendra Kumar Jain
Journal:  AAPS PharmSciTech       Date:  2014-01-16       Impact factor: 3.246

3.  Supramolecular filaments containing a fixed 41% paclitaxel loading.

Authors:  Ran Lin; Andrew G Cheetham; Pengcheng Zhang; Yi-an Lin; Honggang Cui
Journal:  Chem Commun (Camb)       Date:  2013-05-28       Impact factor: 6.222

4.  Pharmacokinetics of paclitaxel-containing liposomes in rats.

Authors:  Gerald J Fetterly; Robert M Straubinger
Journal:  AAPS PharmSci       Date:  2003-11-21

5.  Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs.

Authors:  Aparna Krishnadas; Israel Rubinstein; Hayat Onyüksel
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

6.  Liquid-liquid extraction for recovery of paclitaxel from plant cell culture: solvent evaluation and use of extractants for partitioning and selectivity.

Authors:  Timothy J McPartland; Rohan A Patil; Michael F Malone; Susan C Roberts
Journal:  Biotechnol Prog       Date:  2012-06-18

Review 7.  A critical review of lipid-based nanoparticles for taxane delivery.

Authors:  Lan Feng; Russell J Mumper
Journal:  Cancer Lett       Date:  2012-07-13       Impact factor: 8.679

8.  A liposomal formulation able to incorporate a high content of Paclitaxel and exert promising anticancer effect.

Authors:  Pei Kan; Chih-Wan Tsao; Ae-June Wang; Wu-Chou Su; Hsiang-Fa Liang
Journal:  J Drug Deliv       Date:  2010-10-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.